PrintChina’s pharmaceutical market is currently ninth largest worldwide and worth approximately $25 billion. With analysts predicting this market to be fifth largest by 2013, one cannot ignore China’s potential. This webcast will provide an overview of drug registration in China as well as discuss the most recent regulatory issues of the Chinese State Food and Drug Administration (SFDA). This 90-minute session will include a 60-minute presentation, followed by 30 minutes of Q&A.
The following topics will be covered in this webcast:
- Overview of China Healthcare
- China Pharmaceutical Market Industry Overview
- Drug Registration Policy
- Pharmaceutical Manufacturing Regulations
- Classification of Drugs
- Drug Registration Application
- Drug Pricing
- Clinical Trials
- Reimbursement Strategy
- Required Steps to get Reimbursement
- Post-marketing surveillance and quality control
- Intellectual Property
Who should attend:
This webcast is designed for professionals who want to be current on the Chinese pharmaceutical market.
Please see our website www.pacificbridgemedical.com for additional information and our upcoming schedule.